Pre-hospital oxygen therapy and saturation variability in COVID-19 patients with and without glucose metabolism disorders: part of the COLOS Study

• Published in: Scientific reports Vol. 14; no. 1; pp. 19286 - 19
• Main Authors: Bronowicka-Szydełko, Agnieszka, Lewandowski, Łukasz, Lubieniecki, Pawel, Adamiec-Mroczek, Joanna, Doroszko, Adrian, Trocha, Małgorzata, Kujawa, Krzysztof, Matera-Witkiewicz, Agnieszka, Rabczyński, Maciej, Kuźnik, Edwin, Madziarski, Marcin, Sokołowski, Janusz, Jankowska, Ewa A., Madziarska, Katarzyna
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 20.08.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 692/699; 692/699/255; 692/699/75; Aged; Albumin; Beta cells; Cell membranes; COVID-19; COVID-19 - blood; COVID-19 - therapy; Creatinine; Depolarization; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - metabolism; Diabetes Mellitus, Type 2 - therapy; Female; Glucose; Glucose metabolism; Glucose Metabolism Disorders - blood; Glucose Metabolism Disorders - therapy; Hospitalization; Humanities and Social Sciences; Humans; Insulin secretion; Lymphocytes; Male; Membrane potential; Metabolic disorders; Middle Aged; multidisciplinary; Oxygen; Oxygen - metabolism; Oxygen Inhalation Therapy - methods; Oxygen Saturation; Oxygen therapy; Pandemics; Potassium; Procalcitonin; SARS-CoV-2 - isolation & purification; Saturation; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Troponin; Troponin T

The COVID-19 pandemic has revealed that viruses can have multiple receptor properties, penetrating various tissues and causing mutations in various genes, thus promoting a range of metabolic disorders. The purpose of this study was to investigate the connection between three factors: diabetic status...